Oramed (ORMP) Stock Skyrockets Amid Joint Venture Development Plans
After Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) announced a strategic joint venture for the development and commercialization of its oral medication delivery technology, the company’s shares shot up the charts today. At $2.84 as of the most recent trading session, ORMP shares had risen 30.65%. OraTech Pharmaceuticals’ establishment A new company called OraTech Pharmaceuticals Inc. was …
Oramed (ORMP) Stock Skyrockets Amid Joint Venture Development Plans Read More »